Hanan Tanash
21 – 30 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers : a cross-sectional study
(
- Contribution to journal › Article
-
Mark
Decreased risk of ischemic heart disease in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison with the general population
(
- Contribution to journal › Article
- 2019
-
Mark
Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years
(
- Contribution to journal › Article
-
Mark
Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
The association of body mass index, weight gain and central obesity with activity-related breathlessness : The Swedish Cardiopulmonary Bioimage Study
(
- Contribution to journal › Article
-
Mark
Liver disease in adults with severe alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
- 2018
-
Mark
Lung function and CT lung densitometry in 37-to 39-year-old individuals with alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
- 2017
-
Mark
Burn injury during long-term oxygen therapy in Denmark and Sweden : The potential role of smoking
(
- Contribution to journal › Article
-
Mark
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years
(
- Contribution to journal › Article
-
Mark
Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
(
- Contribution to journal › Article